Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MJBiz is the leading B2B media, events, and data provider for the cannabis and hemp industries. Founded in 2011 as Marijuana Business Daily, the company produces MJBizCon, the world's largest cannabis trade show, and provides specialized news, analysis, and market research through its various publications. MJBiz also focuses on the scientific and pharmaceutical aspects of the industry through its MJBizScience division and The Emerald Conference, which cover cannabinoid research, clinical trials, and drug development. The company provides essential market data and regulatory analysis that supports biotech and pharma companies operating in the cannabinoid space. In January 2022, the company was acquired by Emerald Holding, Inc. for $120 million.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MJBiz.